{
  "id": 12280099,
  "name": "COMMONWEALTH of Pennsylvania, Appellant v. TAP PHARMACEUTICAL PRODUCTS, INC.; Abbott Laboratories; Astrazeneca PLC; Astrazeneca, Holdings, Inc.; Astrazeneca Pharmaceuticals LP; Astrazeneca LP; Bayer AG; Bayer Corporation; SmithKline Beecham Corporation d/b/a GlaxoSmithKline; Pfizer, Inc.; Pharmacia Corporation; Johnson & Johnson; Alza Corporation; Centrocor, Inc.; Ethicon, Inc.; Janssen Pharmaceutical Products, L.P.; McNeil-PPC, Inc.; Ortho Biotech, Inc.; Ortho Biotech Products; L.P.; Ortho-McNeil Pharmaceutical, Inc.; Amgen, Inc.; Immunex Corporation; Bristol-Myers Squibb Company; Baxter International Inc.; Baxter Healthcare Corporation; Immuno-U.S., Inc.; Aventis Pharmaceuticals, Inc.; Aventis Behring, L.L.C.; Hoechst Marion Roussel, Inc., Boehringer Ingelheim Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; Ben Venue Laboratories; Bedford Laboratories; Roxane Laboratories; Schering-Plough Corporation; Warrick Pharmaceuticals Corporation; Schering Sales Corporation; Dey, Inc., Appellees. Donna A. Boswell, Esq., Ann M. Vickery, Esq., and Joseph A. Young, Esq., Intervenors. Cross Appeal of Johnson & Johnson, Alza Corporation, Centocor, Inc., Ethicon, Inc., Janssen Pharmaceutical Products, L.P., McNeil-PPC, Inc., Ortho Biotech, Inc., Ortho Biotech Products, L.P., and Ortho-McNeil Pharmaceutical, Inc. (Collectively, the \"Johnson & Johnson Defendants\") (@ 20 MAP 2015)",
  "name_abbreviation": "Commonwealth v. TAP Pharmaceutical Products, Inc.",
  "decision_date": "2015-12-21",
  "docket_number": "No. 212 MD 2004; Nos. 13 & 20 MAP 2015",
  "first_page": "34",
  "last_page": "35",
  "citations": [
    {
      "type": "official",
      "cite": "634 Pa. 34"
    },
    {
      "type": "parallel",
      "cite": "128 A.3d 1202"
    }
  ],
  "court": {
    "name_abbreviation": "Pa.",
    "id": 8832,
    "name": "Supreme Court of Pennsylvania"
  },
  "jurisdiction": {
    "id": 6,
    "name_long": "Pennsylvania",
    "name": "Pa."
  },
  "cites_to": [],
  "analysis": {
    "cardinality": 108,
    "char_count": 1632,
    "ocr_confidence": 0.666,
    "pagerank": {
      "raw": 4.688403287882615e-08,
      "percentile": 0.2546911043568756
    },
    "sha256": "584fce9150168276a0f081cc10e45a26a75a175d779db1ff029f18ec271fb054",
    "simhash": "1:47dbfa6b415a1b49",
    "word_count": 198
  },
  "last_updated": "2023-07-14T15:35:14.432984+00:00",
  "provenance": {
    "date_added": "2018-10-23",
    "source": "Harvard",
    "batch": "2018"
  },
  "casebody": {
    "judges": [
      "Justice STEVENS did not participate in the decision of this case."
    ],
    "parties": [
      "COMMONWEALTH of Pennsylvania, Appellant v. TAP PHARMACEUTICAL PRODUCTS, INC.; Abbott Laboratories; Astrazeneca PLC; Astrazeneca, Holdings, Inc.; Astrazeneca Pharmaceuticals LP; Astrazeneca LP; Bayer AG; Bayer Corporation; SmithKline Beecham Corporation d/b/a GlaxoSmithKline; Pfizer, Inc.; Pharmacia Corporation; Johnson & Johnson; Alza Corporation; Centrocor, Inc.; Ethicon, Inc.; Janssen Pharmaceutical Products, L.P.; McNeil-PPC, Inc.; Ortho Biotech, Inc.; Ortho Biotech Products; L.P.; Ortho-McNeil Pharmaceutical, Inc.; Amgen, Inc.; Immunex Corporation; Bristol-Myers Squibb Company; Baxter International Inc.; Baxter Healthcare Corporation; Immuno-U.S., Inc.; Aventis Pharmaceuticals, Inc.; Aventis Behring, L.L.C.; Hoechst Marion Roussel, Inc., Boehringer Ingelheim Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; Ben Venue Laboratories; Bedford Laboratories; Roxane Laboratories; Schering-Plough Corporation; Warrick Pharmaceuticals Corporation; Schering Sales Corporation; Dey, Inc., Appellees. Donna A. Boswell, Esq., Ann M. Vickery, Esq., and Joseph A. Young, Esq., Intervenors. Cross Appeal of Johnson & Johnson, Alza Corporation, Centocor, Inc., Ethicon, Inc., Janssen Pharmaceutical Products, L.P., McNeil-PPC, Inc., Ortho Biotech, Inc., Ortho Biotech Products, L.P., and Ortho-McNeil Pharmaceutical, Inc. (Collectively, the \u201cJohnson & Johnson Defendants\u201d) (@ 20 MAP 2015)."
    ],
    "opinions": [
      {
        "text": "ORDER\nPER CURIAM.\nAND NOW, this 21st day of December, 2015, the Order of the Commonwealth Court is AFFIRMED.\nJustice STEVENS did not participate in the decision of this case.",
        "type": "majority",
        "author": "PER CURIAM."
      }
    ],
    "attorneys": [],
    "corrections": "",
    "head_matter": "128 A.3d 1202\nCOMMONWEALTH of Pennsylvania, Appellant v. TAP PHARMACEUTICAL PRODUCTS, INC.; Abbott Laboratories; Astrazeneca PLC; Astrazeneca, Holdings, Inc.; Astrazeneca Pharmaceuticals LP; Astrazeneca LP; Bayer AG; Bayer Corporation; SmithKline Beecham Corporation d/b/a GlaxoSmithKline; Pfizer, Inc.; Pharmacia Corporation; Johnson & Johnson; Alza Corporation; Centrocor, Inc.; Ethicon, Inc.; Janssen Pharmaceutical Products, L.P.; McNeil-PPC, Inc.; Ortho Biotech, Inc.; Ortho Biotech Products; L.P.; Ortho-McNeil Pharmaceutical, Inc.; Amgen, Inc.; Immunex Corporation; Bristol-Myers Squibb Company; Baxter International Inc.; Baxter Healthcare Corporation; Immuno-U.S., Inc.; Aventis Pharmaceuticals, Inc.; Aventis Behring, L.L.C.; Hoechst Marion Roussel, Inc., Boehringer Ingelheim Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; Ben Venue Laboratories; Bedford Laboratories; Roxane Laboratories; Schering-Plough Corporation; Warrick Pharmaceuticals Corporation; Schering Sales Corporation; Dey, Inc., Appellees. Donna A. Boswell, Esq., Ann M. Vickery, Esq., and Joseph A. Young, Esq., Intervenors. Cross Appeal of Johnson & Johnson, Alza Corporation, Centocor, Inc., Ethicon, Inc., Janssen Pharmaceutical Products, L.P., McNeil-PPC, Inc., Ortho Biotech, Inc., Ortho Biotech Products, L.P., and Ortho-McNeil Pharmaceutical, Inc. (Collectively, the \u201cJohnson & Johnson Defendants\u201d) (@ 20 MAP 2015).\nSupreme Court of Pennsylvania.\nDec. 21, 2015."
  },
  "file_name": "0034-01",
  "first_page_order": 78,
  "last_page_order": 79
}
